Profiel
Kevin J.
Ontiveros served as Vice President-Corporate Law & Assistant Secretary at NPS Pharmaceuticals, Inc. from 1996 to 2007.
He then worked as Secretary, VP-Legal Affairs & General Counsel at ImaRx Therapeutics, Inc. He later served as Secretary, Chief Legal & Compliance Officer at SINTX Technologies, Inc. from 2013 to 2015.
Ontiveros received his undergraduate degree from the University of Arizona, his graduate degree from the University of Florida, and his law degree from S.J.
Quinney College of Law.
Eerdere bekende functies van Kevin J. Ontiveros
| Bedrijven | Functie | Einde |
|---|---|---|
| SINTX TECHNOLOGIES, INC. | Compliance Officer | 08-01-2015 |
ImaRx Therapeutics, Inc.
 ImaRx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImaRx Therapeutics, Inc. manufactures biopharmaceutical products. The company develops and manufactures therapies for vascular disorders associated with blood clots based on two programs, thrombolytics and sonoLysis. Its therapeutics products are approved by the US Food, Drug Administration and FDA, for the treatment of acute pulmonary embolism or blood clots in the lungs. The company was founded in 1991 and is headquartered in Los Angeles, CA | Algemeen Adviseur | 11-06-2008 |
| NPS PHARMACEUTICALS, INC. | Algemeen Adviseur | - |
Opleiding van Kevin J. Ontiveros
| University of Florida | Graduate Degree |
| University of Arizona | Undergraduate Degree |
| S.J. Quinney College of Law | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| SINTX TECHNOLOGIES, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
NPS Pharmaceuticals, Inc.
 NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NPS Pharmaceuticals, Inc. developed drugs for bone and mineral disorders. It also developed Natpara for the treatment of adult hypoparathyroidism. The company was founded by Hunter Jackson and Thomas N. Parks on October 22, 1986 and is headquartered in Bedminster, NJ. | Health Technology |
ImaRx Therapeutics, Inc.
ImaRx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImaRx Therapeutics, Inc. manufactures biopharmaceutical products. The company develops and manufactures therapies for vascular disorders associated with blood clots based on two programs, thrombolytics and sonoLysis. Its therapeutics products are approved by the US Food, Drug Administration and FDA, for the treatment of acute pulmonary embolism or blood clots in the lungs. The company was founded in 1991 and is headquartered in Los Angeles, CA | Health Technology |
